Approval · Notice of Compliance 563 · 2002
ROBINUL: Notice of Compliance 563
Issued July 16, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 563
- Date
- July 16, 2002
- Company
- First Horizon Pharmaceutical Corp.Alpharetta, Georgia, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticholinergic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROBINUL | 02246196 | — |
| ROBINUL FORTE | 02246195 | — |
Medicinal ingredients
- GLYCOPYRROLATE 1 MG per TAB
- GLYCOPYRROLATE 2 MG per TAB